- Home
- NMRA vs DAVA Comparison
NMRA vs DAVA Comparison
Compare NMRA & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMRA | DAVA |
|---|---|---|
| Founded | 2019 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 424.4M | 356.2M |
| IPO Year | 2023 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NMRA | DAVA |
|---|---|---|
| Price | $1.98 | $6.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $8.00 | ★ $16.33 |
| AVG Volume (30 Days) | 980.8K | ★ 1.2M |
| Earning Date | 11-06-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.26 |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $1,015,391,026.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.62 |
| P/E Ratio | ★ N/A | $26.12 |
| Revenue Growth | N/A | ★ 1.07 |
| 52 Week Low | $0.61 | $6.02 |
| 52 Week High | $11.57 | $34.94 |
Technical Indicators
Market Signals| Indicator | NMRA | DAVA |
|---|---|---|
| Relative Strength Index (RSI) | 35.79 | 49.84 |
| Support Level | $2.05 | $6.02 |
| Resistance Level | $2.36 | $6.78 |
| Average True Range (ATR) | 0.14 | 0.30 |
| MACD | -0.04 | 0.16 |
| Stochastic Oscillator | 4.44 | 97.45 |
Price Performance
Historical ComparisonAbout NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.